This medication is a radioactive diagnostic agent, used to detect tumor site in patients with breast cancer or melanoma.
SC- The recommended dose is 18.5 MBq (0.5 mCi), at least 15 minutes before initiating intraoperative lymphatic mapping.
It comes as a powder for injection to be administered by a healthcare provider either under the skin or peritumoral administration.
• Patient may develop with increased of hypersensitivity reactions; if it is so consult with your doctor.
• Caution needed for pregnant and breastfeeding women.
Injection site irritation and pain.
Avoid excess dosage.
Store it in controlled room temperature 20° to25°C.
Subscribe to our Free Newsletters!
Lofexidine tablets for oral use were approved by FDA in May 2018, for reducing the intensity of ...
Tularemia is an uncommon, highly contagious bacterial infection acquired in humans by insect bites ...
Nipah Virus (NiV) or Hendra virus is a deadly virus that spreads via contact with the saliva, ...View All